Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Target doses of guideline-directed medical therapeutic agents predicts response to cardiac resynchronization therapy.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Spironolactone improves left atrial function and atrioventricular coupling in patients with resistant hypertension.

The international journal of cardiovascular imaging·2023
Same author

Replicative Study in Performance-Related Genes of Brazilian Elite Soccer Players Highlights Genetic Differences from African Ancestry and Similarities between Professional and U20 Youth Athletes.

Genes·2023
Same author

Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2023
Same author

Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.

Hypertension (Dallas, Tex. : 1979)·2022
Same author

Diastolic function: modeling left ventricular untwisting as a damped harmonic oscillator.

Physiological measurement·2022

Related Experiment Video

Updated: Jun 26, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Aldosterone and cardiovascular disease.

Krishna K Gaddam, Eduardo Pimenta, Saima Husain

    Current Problems in Cardiology
    |January 13, 2009
    PubMed
    Summary

    Aldosterone, a key adrenal hormone, is increasingly recognized as a common cause of hypertension. Its role in cardiovascular diseases like heart failure and kidney disease is supported by studies and treatment responses.

    Area of Science:

    • Endocrinology
    • Cardiovascular Medicine
    • Nephrology

    Background:

    • Aldosterone is an adrenal hormone crucial for regulating sodium, fluid, and potassium balance.
    • Primary aldosteronism, characterized by excessive aldosterone secretion, is now understood to be a prevalent cause of hypertension (5-10% of hypertensive patients).

    Purpose of the Study:

    • To review the multifaceted role of aldosterone in various cardiovascular disease processes.
    • To explore the potential mechanisms underlying aldosterone's impact on target organs.
    • To discuss current and potential therapeutic strategies targeting the aldosterone pathway.

    Main Methods:

    • Review of animal models demonstrating aldosterone's effects on target-organ inflammation and fibrosis.
    • Analysis of cross-sectional and observational human studies linking aldosterone to cardiovascular and metabolic diseases.

    More Related Videos

    Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
    12:03

    Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

    Published on: June 7, 2016

    Related Experiment Videos

    Last Updated: Jun 26, 2026

    Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
    07:36

    Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

    Published on: September 26, 2018

    Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
    12:03

    Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

    Published on: June 7, 2016

  • Evaluation of interventional studies on mineralocorticoid receptor antagonists in cardiovascular conditions.

    • Main Results:

    • Aldosterone, particularly with high salt intake, induces target-organ inflammation and fibrosis in animal models.
    • Human studies associate aldosterone with the development and severity of hypertension, heart failure, coronary artery disease, chronic kidney disease, and metabolic syndrome.
    • Mineralocorticoid receptor antagonists show beneficial effects in hypertension, heart failure, and post-myocardial infarction, supporting aldosterone's pathogenic role.

    Conclusions:

    • Aldosterone plays a significant role in the pathogenesis of numerous cardiovascular diseases.
    • Targeting the mineralocorticoid receptor offers a promising therapeutic avenue for managing aldosterone-mediated conditions.
    • Further research into aldosterone's mechanisms and treatment is warranted.